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Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biom-
arker secreted in the atherosclerotic plaque. The main objective of this study is
to compare Lp-PLA2 with CCA in AS-patients prior to aortic valve surgery and
to evaluate Lp-PLA2 as an independent predictor of associated CAD.
Methods and Results: 285 patients with AS and/or CAD were included
into 3 groups: “CAD-Group”: stable CAD; “AS-Group”: AS and normal cor-
onary arteries and “AS-CAD-Group”: AS and stable CAD associated. Lp-
PLA2 mass concentration was assessed in serum with a Plac®-test turbidi-
metric immunoassay. Normal Lp-PLA2 values of the lipids laboratory were
specifically obtained from 61 healthy Caucasian volunteers.
In healthy controls, Lp-PLA2 was 163±43 μg/L. Lp-PLA2 was signifi-
cantly higher in patients than in controls (219.2±49.1 vs 163.0±43.0 μg/L;
p=0.01) and was significantly higher in the AS-CAD group (246±51 μg/L,
p<0.001) than in the 2 other groups (AS: 217±44; CAD: 215±48 μg/L). Lp-
PLA2 appeared to be an independent prognostic factor for CAD in patients
with AS (total r=0.76; p=0.005) with a rule-out value of 230 µg/L. Lp-PLA2
was found to have 80.1% sensitivity, 58.6% specificity to separate AS with or
without CAD, while PPV and NPV were 70% and 58%, respectively.
Conclusion: Our results suggest that in patients with severe AS, Lp-
PLA2 could correlate with associated stable CAD, with a rule-out value of
230 µg/L, and may be helpful to select patients requiring coronary angio-
graphy before cardiac valve surgery.
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Objectives: The purpose of this study was to evaluate the efficacy and
safety of transcatheter aortic valve implantation (TAVI) in patients with small
body size (SB).
Background: Clinical outcome of TAVI in patients with SB remains unclear.
Methods: Between October 2006 and November 2011, 424 patients with
severe aortic stenosis undergoing TAVI were evaluated. The cohort with small
body surface area of <1.75 m2 was defined as the “SB group” (n=215) and the
rest of the cohort with large body-size as the “LB group” (n=209). 
Results: In the SB group, the aortic annulus and femoral artery diameter
were significantly smaller (23.0±1.86 vs 24.3±1.94 mm, p <0.001; 7.59±1.06 vs
8.29±1.34 mm, p <0.001, respectively). The logistic EuroSCORE was similar
between the groups (22.5±10.4 vs 23.4±12.0, p=0.433). Equivalent device suc-
cess (91.2 vs 91.4%, p=0.935) and 30-day survival rates (85.1 vs 87.6%,
p=0.464) were achieved in both groups. Vascular complications were signifi-
cantly higher in the SB group (13.0% vs 4.3%, p=0.002). Similar post-proce-
dural mean pressure gradient was achieved in both groups (10.2±4.3 vs 11.0±4.6
mmHg, p=0.119). Kaplain-Meier survival analysis revealed no significant dif-
ference in the mid-term survival between groups (log-rank p=0.642). 
Conclusions: TAVI in patients with SB resulted in similar clinical out-
comes with effective post-procedural hemodynamics compared with LB. Care
should be taken to avoid vascular complication in patients with SB.
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In recent studies, the impact of a low or high body mass index (BMI)
on outcome after cardiac surgery has been the subject of controversy. Our
study was conducted to determine the influence of BMI on late mortality
after aortic valve replacement (AVR) in pts with significant aortic stenosis
(AS).
Methods: 1150 pts (42% women, mean age of 6510 yrs) were observed
mean 7,54 yrs (40 days to 13 yrs) after AVR due to significant, isolated
AS (99% complete). BMI was divided in three groups: <25 kg/m2
(478 pts), 25-30 kg/m2 (472 pts) and >35 kg/m2 (200 pts). During 10 yrs
221 deaths were recorded – 70 women (14,6%) and 151 men (22,7%) –
p=0,001. 
Results: Kaplan-Meier analysis of survival was assessed. The differences
were observed in whole group (0,04) and in men (p=0,001) but not in women
(NS). Male patients with BMI <25 and>30 kg/m2 had higher risk of death in
comparison to those with BMI 25-30 kg/m2.
Conclusion: The survival after aortic valve replacement is related to body
mass index only in male patients – BMI <25 kg/m2 and >30 kg/m2 is predic-
tive of an increased risk of late mortality.
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It has been shown during the past few years that woman’s heart is different
than man’s. It is stressed, that women are on increased risk of aortic valve
replacement (AVR) due to greater hypertrophy and worse its regression.
Objective: The aim of the study was to estimate whether the survive after
AVR is gender related or there are any other parameters which have impact
on follow up after surgery in aortic stenosis (AS). 
Methodology: 993 pts (408 women, age 65±10 yrs) after AVR due to AS
were observed mean 7,5±4 yrs after surgery. Following parameters were taken
into account: gender, age, significance of AS (transaortic gradient – MAG),
left ventricle hypertrophy (mass index- LVMI), ejection fraction (EF) and
presence of coronary artery stenosis (CAD) assessed before AVR.
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The results of Cox regression analysis are shown in the table. Additionally
we analyzed the factors related with survival in men and women separately.
They were comparable in both groups except the presence of CAD that had
borderline impact only on 10 yrs survival in men.
Conclusion: The survival after aortic valve replacement is much worse in
men. The reason is unknown but it is not explained by the presence of the
coronary artery disease.
Table – Results
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Background: Preoperative risk assessment of cardiac surgery is based on
international validated scores. However their additional value above simple clin-
ical assessment (CA) remains controversial. The aim of this study was to compare
CA by cardiologists with the 5 most commonly used scores (additive and logistic
EuroSCORE, EuroSCORE II, STS-score, Ambler-score) to predict perioperative
mortality in patients undergoing aortic valve replacement for aortic stenosis.
Methods: From October 2009 to November 2011, 314 consecutive patients
(73±9,7 years; 29% octogenarians) were included. A surgical coronary revas-
cularization was associated to aortic valve replacement in 22%. According to
the expected mortality by CA, patients were split in 4 groups: “low” mortality
risk [0-3.9%], “intermediate” [4-6.9%], “high” [7-9.9%] and “very high”
≥10%. The 5 scores were calculated for all the patients.
Results: Observed total operative mortality was 5,7%. The distribution of
predicted mortality in the 4 groups was highly different according to the
method. The positive predictive value (PPV) of each method was calculated
for the 21% most at risk patients (corresponding to the 64 patients ranked in
“high” and “very high” mortality risk groups by CA) resulting in PPV=17.2%
for EuroSCORE II, 14.1% for CA and STS-score, 10.9% for additive EuroS-
CORE and logistic EuroSCORE and 10% for Ambler score. Predictive values
of “low” and “intermediate” mortality risks were not significantly different
depending on the methods (PPV between 2.8 and 4.4%).
Conclusion: pragmatic CA remains useful to predict operative risk in
patients with surgical aortic valve replacement and to balance the different
international scores.
Follow up Deaths Parameters i Odds ratio p=
3 yrs 64 pts Age 1,06 (1,03-1,09) 0,0001
13 women Male gender 3,7 (2,0-6,9) 0,001
51 men EF 1,006 (1,001-1,011 0,03
5 yrs 100 pts Age 1,079 (1,04-1,09) 0,0001
Male gender 3,0 (1,8-4,8) 0,0001
23 women EF 1,007 (1,002-1,01) 0,004
77 men MAG 0,98 (0,97-0,99) 0,0001
7 yrs 140 pts Age 1,06 (1,04-1,08) 0,0001
Male gender 2,4 (1,6-1,08) 0,0001
37 women MAG 0,99 (0,98-0,995) 0,09
103 men LVMI 1,1 (1,0-1,005) 0,0001
10 yrs 199 pts Age 1,05 (1,035-1,07) 0,09
Male gender 1,8 (1,4-2,6) 0,0001
62 women MAG 0,99 (0,86-0,997) 0,0001
137 men CAD 1,3 (0,96-1,8) 0,086
